Gerald J. Atkins
Gerald J. Atkins
Professor of Orthopaedic Research, COTR, University of Adelaide
Verified email at - Homepage
Cited by
Cited by
Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway
AR Wijenayaka, M Kogawa, HP Lim, LF Bonewald, DM Findlay, GJ Atkins
PloS one 6 (10), e25900, 2011
Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1α, 25-dihydroxyvitamin D3
GJ Atkins, PH Anderson, DM Findlay, KJ Welldon, C Vincent, ...
Bone 40 (6), 1517-1528, 2007
Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint
DR Haynes, TN Crotti, M Loric, GI Bain, GJ Atkins, DM Findlay
Rheumatology 40 (6), 623-630, 2001
Receptor activator of nuclear factor-κB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo
AN Farrugia, GJ Atkins, LB To, B Pan, N Horvath, P Kostakis, DM Findlay, ...
Cancer research 63 (17), 5438-5445, 2003
RANKL expression is related to the differentiation state of human osteoblasts
GJ Atkins, P Kostakis, B Pan, A Farrugia, S Gronthos, A Evdokiou, ...
Journal of Bone and Mineral Research 18 (6), 1088-1098, 2003
Biocompatible polymer coating of titania nanotube arrays for improved drug elution and osteoblast adhesion
K Gulati, S Ramakrishnan, MS Aw, GJ Atkins, DM Findlay, D Losic
Acta biomaterialia 8 (1), 449-456, 2012
The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis
DR Haynes, TN Crotti, AE Potter, M Loric, GJ Atkins, DW Howie, ...
The Journal of Bone and Joint Surgery. British Volume 83 (6), 902-911, 2001
The proliferation and phenotypic expression of human osteoblasts on tantalum metal
DM Findlay, K Welldon, GJ Atkins, DW Howie, ACW Zannettino, D Bobyn
Biomaterials 25 (12), 2215-2227, 2004
Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls
DR Haynes, E Barg, TN Crotti, C Holding, H Weedon, GJ Atkins, ...
Rheumatology 42 (1), 123-134, 2003
Sclerostin is a locally acting regulator of late‐osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE‐ASARM‐dependent mechanism
GJ Atkins, PS Rowe, HP Lim, KJ Welldon, R Ormsby, AR Wijenayaka, ...
Journal of Bone and Mineral Research 26 (7), 1425-1436, 2011
Expression of osteoclast differentiation signals by stromal elements of giant cell tumors
GJ Atkins, DR Haynes, SE Graves, A Evdokiou, S Hay, S Bouralexis, ...
Journal of Bone and Mineral Research 15 (4), 640-649, 2000
Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response
GJ Atkins, KJ Welldon, P Halbout, DM Findlay
Osteoporosis International 20 (4), 653-664, 2009
Osteoprotegerin (OPG) is localized to the Weibel‐Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor
ACW Zannettino, CA Holding, P Diamond, GJ Atkins, P Kostakis, ...
Journal of cellular physiology 204 (2), 714-723, 2005
TWEAK is a novel arthritogenic mediator
SJ Perper, B Browning, LC Burkly, S Weng, C Gao, K Giza, L Su, ...
The Journal of Immunology 177 (4), 2610-2620, 2006
Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL‐induced apoptosis
A Evdokiou, S Bouralexis, GJ Atkins, F Chai, S Hay, M Clayer, DM Findlay
International journal of cancer 99 (4), 491-504, 2002
Pro‐inflammatory cytokines TNF‐related weak inducer of apoptosis (TWEAK) and TNFα induce the mitogen‐activated protein kinase (MAPK)‐dependent expression of sclerostin in human…
C Vincent, DM Findlay, KJ Welldon, AR Wijenayaka, TS Zheng, ...
Journal of bone and mineral research 24 (8), 1434-1449, 2009
Osteocyte regulation of bone mineral: a little give and take
GJ Atkins, DM Findlay
Osteoporosis international 23 (8), 2067-2079, 2012
The ratio of messenger RNA levels of receptor activator of nuclear factor κB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone…
NL Fazzalari, JS Kuliwaba, GJ Atkins, MR Forwood, DM Findlay
Journal of Bone and Mineral Research 16 (6), 1015-1027, 2001
Osteoclastic Metabolism of 25(OH)-Vitamin D3: A Potential Mechanism for Optimization of Bone Resorption
M Kogawa, DM Findlay, PH Anderson, R Ormsby, C Vincent, HA Morris, ...
Endocrinology 151 (10), 4613-4625, 2010
Bril: a novel bone‐specific modulator of mineralization
P Moffatt, MH Gaumond, P Salois, K Sellin, MC Bessette, Godin, ...
Journal of Bone and Mineral Research 23 (9), 1497-1508, 2008
The system can't perform the operation now. Try again later.
Articles 1–20